Skip to main content

Coulter James G's Form 4 filing

Odyssey Therapeutics, Inc. (ODTX) · filed May 13, 2026

Accession no.
0001999371-26-010652
Filed
May 13, 2026, 5:10 PM ET
Trade date
May 11, 2026
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market purchases total $25.0M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Coulter James GCIK 0001099776Other: Former 10% Owner
Winkelried JonCIK 0001366946Other: Former 10% Owner
TPG GP A, LLCCIK 0001903793Other: Former 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 11, 2026Common StockJOtherAcquired+423,111––423,111Indirect
May 11, 2026Common StockJOtherDisposed−2,351$18.00−$42,318420,760Indirect
May 11, 2026Common StockCConversionAcquired+1,880,497––2,301,257Indirect
May 11, 2026Common StockPPurchaseAcquired+1,388,889$18.00+$25,000,0023,690,146Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 11, 2026Common StockJOtherDisposed−423,111––0Indirect
May 11, 2026Common StockCConversionDisposed−1,880,497––0Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)